CN1107337A - Compound gynostemma pentaphyllum oral liquid - Google Patents
Compound gynostemma pentaphyllum oral liquid Download PDFInfo
- Publication number
- CN1107337A CN1107337A CN 94101451 CN94101451A CN1107337A CN 1107337 A CN1107337 A CN 1107337A CN 94101451 CN94101451 CN 94101451 CN 94101451 A CN94101451 A CN 94101451A CN 1107337 A CN1107337 A CN 1107337A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- herb gynostemmae
- gynostemmae pentaphylli
- dauci sativae
- radix dauci
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 26
- 240000006509 Gynostemma pentaphyllum Species 0.000 title claims abstract description 12
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 title claims abstract description 12
- 150000001875 compounds Chemical class 0.000 title claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 239000012153 distilled water Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 4
- 230000008020 evaporation Effects 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000002203 pretreatment Methods 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 238000010009 beating Methods 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 6
- 239000011573 trace mineral Substances 0.000 abstract description 4
- 235000013619 trace mineral Nutrition 0.000 abstract description 4
- 235000001014 amino acid Nutrition 0.000 abstract description 3
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 208000006454 hepatitis Diseases 0.000 abstract description 3
- 231100000283 hepatitis Toxicity 0.000 abstract description 3
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 2
- 208000006673 asthma Diseases 0.000 abstract description 2
- 238000000227 grinding Methods 0.000 abstract description 2
- 244000000626 Daucus carota Species 0.000 abstract 2
- 235000002767 Daucus carota Nutrition 0.000 abstract 2
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 2
- 244000182216 Mimusops elengi Species 0.000 abstract 2
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 2
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 2
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 2
- 230000000020 effect on hyperlipemia Effects 0.000 abstract 1
- 201000005917 gastric ulcer Diseases 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 238000004537 pulping Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- TXVHTIQJNYSSKO-UHFFFAOYSA-N BeP Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC4=CC=C1C2=C34 TXVHTIQJNYSSKO-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- SMVZDCVZXKQERC-UHFFFAOYSA-N guanidine;nitrous acid Chemical compound ON=O.NC(N)=N SMVZDCVZXKQERC-UHFFFAOYSA-N 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 150000002669 lysines Chemical class 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a gynostemma pentaphylla compound oral liquid. The oral liquid comprises herba Gynostemmatis and fructus Lycii as main components, and also contains radix Dauci Sativae, fructus Jujubae and Mel. The preparation method comprises decocting herba Gynostemmatis for three times to obtain extractive solution; secondly, pretreating, pulping and filtering the medlar, the carrot and the jujube, and treating an extracting solution of the medlar, the carrot and the jujube; and thirdly, mixing the extract obtained in the last two steps with honey and distilled water, stirring, grinding, sterilizing and bottling.
The compound gynostemma pentaphylla oral liquid contains 18 kinds of amino acids, vitamins and trace elements essential for human body, and has high curative effect on hyperlipemia, hepatitis, hepatocirrhosis, trachitis, asthma, gastric ulcer, etc. and high mutation resisting effect.
Description
The present invention relates to a kind of oral liquid, particularly based on the oral liquid of Herb Gynostemmae Pentaphylli composition.
The natural plants Herb Gynostemmae Pentaphylli has suitable wide biological activity, the effect that at first has building body, and activate the effect of body emergency reaction in addition, the medical value of Herb Gynostemmae Pentaphylli is very high, modern medicine circle is confirmed both at home and abroad, Herb Gynostemmae Pentaphylli contains 83 kinds of ginsenoside's constituents, to treatment and prophylaxis of hypertension, diabetes, constipation, hemorrhoid, asthma, migraine, senile plaque, diseases such as young bean have magical effect, and calmness arranged, hypnosis, allaying tiredness, appetite stimulator and anti-aging effects, to swelling and ache, hyperlipidemia, hepatitis, tracheitis, gastric and duodenal ulcers, coronary heart disease, arteriosclerosis, diseases such as cholelithiasis and poliosis are bald all have good efficacy, experiment showed, that Herb Gynostemmae Pentaphylli can suppress AIDS.People have been processed into Herb Gynostemmae Pentaphylli Herb Gynostemmae Pentaphylli wine, Herb Gynostemmae Pentaphylli tea and various Herb Gynostemmae Pentaphylli food at present, make it become ideal health-care good product.For increasing the drug effect of Herb Gynostemmae Pentaphylli, also can be made into oral liquid, CN1053188A is disclosed to be exactly a kind of prescription of gynostemium pentaphylla oral liquid, main component is sucrose, Lac regis apis and Mel in this oral liquid, the content of Herb Gynostemmae Pentaphylli is lower, and according to introduction, only contains 7 seed amino acids in this oral liquid.
The object of the present invention is to provide a kind of compound gynostemma pentaphyllum oral liquid, this oral liquid component is based on Herb Gynostemmae Pentaphylli and Fructus Lycii, and contains the multiple nutrients material of needed by human body, to remedy the deficiency of existing gynostemium pentaphylla oral liquid.
Compound gynostemma pentaphyllum oral liquid main component of the present invention is Herb Gynostemmae Pentaphylli and Fructus Lycii, also contains Fructus Jujubae, Radix Dauci Sativae, Mel, and the proportioning of various effective ingredient is as follows:
Herb Gynostemmae Pentaphylli 10-60%
Fructus Lycii 10-50%
Radix Dauci Sativae 5-15%
Fructus Jujubae 1-20%
Mel 2-10%
The preparation process following steps of this oral liquid:
(1) with the roguing of Herb Gynostemmae Pentaphylli raw material, chopping, soak after 5-8 hour, boil three times, each 5-10 minute, and through filtering, three times filtrates are merged, 1/3rd moisture are removed in evaporation, and its extracting solution is waited to prepare burden;
(2) Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae are carried out pre-treatment, after making beating, filtering, its extracting solution is waited to prepare burden;
(3) extracting solution of Herb Gynostemmae Pentaphylli extract and Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae and Mel are mixed with distilled water after the filtration, stir, stir, grind;
(4) oral liquid that is mixed is behind ultraviolet disinfection, and bottling was passed through the room temperature pasteurization 2-3 hour, packed products again.
The compound gynostemma pentaphyllum oral liquid that said method makes, through nutritional labeling and trace element and content of beary metal mensuration, its result is as follows:
Nutrient component determining (I):
The nutritional labeling unit content
Vitamin E mg/100g 0.35
Vitamin B
1Mg/100g 0.01
Vitamin B
2Mg/100g 0.08
Vitamin C mg/100g 10.5
Carotene mg/100g 0.05
Crude protein mg/100g 1.2
Nutrient component determining (II):
Nutrient composition content (mg/100g) nutrient composition content (mg/100g)
Aspartic acid 207 methionine 7
Threonine 21 isoleucine 11
Serine 36 leucines 22
Glutamic acid 141 tyrosine 13
Proline 121 phenylalanine-3,4-quinones 5
Glycine 16 histidine 9
Alanine 49 lysines 9
Cystine 12 arginase 12s 9
Valine 17 tryptophans 9
Determination of trace elements:
Mensuration project content (mg/L) is measured project content (mg/L)
Ferrum 5.33 manganese 0.114
Zinc 1.71 chromium 0.0088
Copper 0.196 stannum 0.0294
Nickel 0.017 selenium 0.005
Germanium＜0.0064 cobalt＜0.0049
Silicon 1930 is with SiO
2Meter molybdenum＜0.0023
Iodide 1.85 vitriol＜0.0070
Fluoride 2.00
Content of beary metal is measured:
Lead is no more than 16mg in per kilogram (1000ml) goods, and mercury content is lower than 100mg, and arsenic is lower than 500mg.
Process experiment showed, that compound gynostemma pentaphyllum oral liquid of the present invention has stronger anti-mutation effect, and has dose-effect relationship, takes by 25ml, and the guanidine nitrite suppression ratio reaches 52%, aflatoxin B
1Suppression ratio reaches 45.2%, and benzo (a) pyrene suppression ratio reaches 40.6%.
In sum, advantage of the present invention is: contained nutrition is more comprehensive, 18 seed amino acids, protein, carotene, multivitamin and the trace element that contain needed by human body, can improve body immunity, all effective in cure to more than 20 kinds of cancers, also have resisting fatigue and anti-aging effects, multiple diseases such as cardiovascular diseases, digestive tract disease, hepatitis cirrhosis are had better prevention and adjuvant treatment effect.
The raw material sources of compound gynostemma pentaphyllum oral liquid of the present invention are extensive, and production technology is simple, and are with low cost.
Several embodiments of the present invention are provided below.
Embodiment 1:
Prescription of the present invention is: Herb Gynostemmae Pentaphylli 18%, Fructus Lycii 45%, Radix Dauci Sativae 12%, Fructus Jujubae 20%, Mel 5%.
The Herb Gynostemmae Pentaphylli raw material is carried out pre-treatment, soak after 6 hours, boil three times, be no more than 10 minutes at every turn, and after filtration, three times filtrates are merged, 1/3rd moisture content are removed in evaporation, and its extracting solution is waited to prepare burden; With the clean fruit of Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae, peeling, after making beating, filtering, its extracting solution is waited to prepare burden: the extracting solution and the Mel of Herb Gynostemmae Pentaphylli extract and Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae are mixed stirring, grinding with filtered distilled water; The oral liquid that is mixed is through behind the ultraviolet disinfection, the 10ml bottle of packing into, again under normal pressure through pasteurization 2-3 hour, packed products.
Embodiment 2:
Prescription of the present invention is: Herb Gynostemmae Pentaphylli 56%, Fructus Lycii 18%, Radix Dauci Sativae 8%, Fructus Jujubae 8%, Mel 10%.
The Herb Gynostemmae Pentaphylli raw material is carried out pre-treatment, soak after 8 hours, boil three times, each 5-10 minute, and through filtering, three times filtrate merges, and 1/3rd moisture are removed in evaporation, and extracting solution is waited to prepare burden; The extracting solution for preparing Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae by the method for embodiment 1; The extracting solution of Herb Gynostemmae Pentaphylli extract, Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae is mixed, the distilled water after adding Mel and filtering, following steps are identical with embodiment 1.
Embodiment 3:
Prescription of the present invention is: Herb Gynostemmae Pentaphylli 32%, Fructus Lycii 38%, Radix Dauci Sativae 10%, Fructus Jujubae 17%, Mel 3%.
Method by embodiment 1 prepares compound gynostemma pentaphyllum oral liquid.
Claims (2)
1, a kind of compound gynostemma pentaphyllum oral liquid is characterized in that containing in this oral liquid component Herb Gynostemmae Pentaphylli, Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae and Mel, and the shared weight ratio of various compositions is:
Herb Gynostemmae Pentaphylli 10-60%
Fructus Lycii 10-50%
Radix Dauci Sativae 5-15%
Fructus Jujubae 1-20%
Mel 2-10%
The each component sum is 100%.
2, the preparation process of compound gynostemma pentaphyllum oral liquid according to claim 1 is characterized in that through following steps:
(1) with the roguing of Herb Gynostemmae Pentaphylli raw material, chopping, soak after 5-8 hour, boil three times, each 5-10 minute, and through filtering, three times filtrates are merged, 1/3rd moisture are removed in evaporation, and its extracting solution is waited to prepare burden;
(2) Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae are carried out pre-treatment, after making beating, filtering, its extracting solution is waited to prepare burden;
(3) extracting solution of Herb Gynostemmae Pentaphylli extract and Fructus Lycii, Radix Dauci Sativae, Fructus Jujubae and Mel are mixed with distilled water after the filtration, stir, stir, grind;
(4) oral liquid that is mixed is behind ultraviolet disinfection, and bottling was passed through the room temperature pasteurization 2-3 hour, packed products again.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94101451 CN1107337A (en) | 1994-02-25 | 1994-02-25 | Compound gynostemma pentaphyllum oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94101451 CN1107337A (en) | 1994-02-25 | 1994-02-25 | Compound gynostemma pentaphyllum oral liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1107337A true CN1107337A (en) | 1995-08-30 |
Family
ID=5030163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94101451 Pending CN1107337A (en) | 1994-02-25 | 1994-02-25 | Compound gynostemma pentaphyllum oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1107337A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100484409C (en) * | 2004-09-01 | 2009-05-06 | 平利县绞股蓝研究所 | Gynostemma pentaphyllum Makino tea for morning, noon and evening |
| CN1742593B (en) * | 2004-09-01 | 2010-07-21 | 平利县绞股蓝研究所 | Gynostemma pentaphyllum makino instant tea |
| CN102579896A (en) * | 2012-02-28 | 2012-07-18 | 熊吉元 | Natural Chinese herbal medicine anticancer pill |
| CN103445155A (en) * | 2013-07-31 | 2013-12-18 | 宫中林 | Compound gynostemma pentaphylla immunity regulating oral liquid |
| CN109349632A (en) * | 2018-11-16 | 2019-02-19 | 安徽迎春草生物科技有限公司 | A kind of anti-aging is welcomed spring careless oral solution and preparation method thereof |
-
1994
- 1994-02-25 CN CN 94101451 patent/CN1107337A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100484409C (en) * | 2004-09-01 | 2009-05-06 | 平利县绞股蓝研究所 | Gynostemma pentaphyllum Makino tea for morning, noon and evening |
| CN1742593B (en) * | 2004-09-01 | 2010-07-21 | 平利县绞股蓝研究所 | Gynostemma pentaphyllum makino instant tea |
| CN102579896A (en) * | 2012-02-28 | 2012-07-18 | 熊吉元 | Natural Chinese herbal medicine anticancer pill |
| CN103445155A (en) * | 2013-07-31 | 2013-12-18 | 宫中林 | Compound gynostemma pentaphylla immunity regulating oral liquid |
| CN109349632A (en) * | 2018-11-16 | 2019-02-19 | 安徽迎春草生物科技有限公司 | A kind of anti-aging is welcomed spring careless oral solution and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101073433A (en) | Blackthorn pear fruit-juice solid product and its production | |
| CN1286403C (en) | Health-care food with immune modulation and cltiradiation function and preparing method thereof | |
| KR20050109269A (en) | A ginseng preparation using vinegar and process for thereof | |
| CN1059791C (en) | Nutrient and health-care liquid produced from dible fungi extract | |
| CN1228066C (en) | Oral liquid for tonifying-kidney and qi contg. eighteen herb medicines, and prepn. method thereof | |
| CN1116894C (en) | Medicine for treating cardiovascular disease and preparation process thereof | |
| CN1062305C (en) | Process for producing edible vinegar with vegetables and product thereof | |
| CN1107337A (en) | Compound gynostemma pentaphyllum oral liquid | |
| CN101380128A (en) | Multifunctional health-care bamboo-sunflower beverage and preparation method thereof | |
| CN1198305A (en) | Nutritious health care fermented glutinous rice and preparing method thereof | |
| CN1042197C (en) | Zhenzhubabaosan-medical powder for curing stomatocace | |
| CN1098918A (en) | Leaves-of-eucommia natural health-care products and production technology thereof | |
| CN1237454A (en) | Health-care medicine with therapeutic action of curing gastropathy and its preparation method | |
| CN1056313C (en) | Functional oral liquor for enhancing human immunity | |
| CN1119076A (en) | Formula of Ilex kudingcha series health food and producing process | |
| CN1064824C (en) | Fruit nectar drink | |
| CN1165024A (en) | Gynostemma pentaphylla royal jelly oral liquid and its preparation method | |
| CN1094291A (en) | Houttuynia oral administration liquid | |
| JP2003212775A (en) | Physiologically active composition | |
| CN1101559A (en) | Traditional Chinese medicine oral administration liquid for anti-cancer and its preparing method | |
| CN1064825C (en) | Fruit nectar powder | |
| CN1269945C (en) | Garlic health nourishing wine and producing method | |
| CN1053356C (en) | Kidney-tonifying and life-prolonging wine | |
| TWI222357B (en) | Anti-ulcer pharmaceutical composition and the preparation and use thereof | |
| CN1077600A (en) | The health care for the middle and old aged bean vermicelli and the method for making thereof that contain natural drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |